Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)

NCT: NCT06404112 · COMPLETED

NCT IDNCT06404112
StatusCOMPLETED
Start Date2024-07-31
Completion2026-04-01
SponsorDuke University (OTHER)
First posted
Last updated

Brief Summary

The platform protocol is designed to be flexible so that it is suitable for a range of study settings and intervention types. Therefore, the platform protocol provides a general protocol structure that can be shared by multiple interventions and allows comparative analysis across the interventions. For example, objectives, measures, and endpoints are generalized in the platform protocol, but intervention-specific features are detailed in separate appendices. This platform protocol is a prospective, multi-center, multi-arm, randomized controlled platform trial evaluating potential interventions for PASC-mediated sleep disturbances. The hypothesis is that symptoms of sleep and circadian disorders that emerge in patients with PASC can be improved by phenotype-targeted interventions. Specific sleep and circadian disorders addressed in this protocol include sleep-related daytime impairment (referred to as hypersomnia) and complex PASC-related sleep disturbance (reflecting symptoms of insomnia and sleep-wake rhythm disturbance).

Frequently Asked Questions

What is RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)?

RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD) is a clinical trial registered under NCT06404112. Current status: COMPLETED.

What is the status of NCT06404112?

The current status of NCT06404112 (RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)) is: COMPLETED.

When did RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD) start?

RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD) started on 2024-07-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.